Use this dropdown to select your preferred language.
Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry’s top investors in research and development, the company focuses on developing innovative therapies that can improve and extend lives in areas of high unmet medical need.
Founded in 1987, Merit Medical Systems, Inc. is a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Merit employs approximately 7,100 people worldwide with facilities.
About Takeda
Takeda is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetics and Hematology, Neuroscience, and Gastroenterology.
QuidelOrtho Corporation (NASDAQ: QDEL) (“QuidelOrtho”) announced completion of the transaction combining Quidel Corporation (“Quidel”) and Ortho Clinical Diagnostics Holdings plc (“Ortho”), creating QuidelOrtho, a leading in vitro diagnostics company. The new company, headquartered in San Diego, California, generated more than $2.8 billion in 2024 and has approximately 7,000 employees.
Amer Sports is a global group of the world’s most recognized and respected sports and outdoor brands.
Amer Sports brands are loved and trusted by millions. Our brands include: Arc’teryx, Salomon, Wilson, PeakPerformance, Atomic, etc.
Elevating the world through sport is our purpose. Our purpose and values unite us across brands and geographies, unlocking our collective power to grow and succeed together.
Chiesi provides AIR, CARE, and RARE therapeutic solutions for a broad range of lung diseases in every step of life, serving millions of patients and families, helping them improve their quality of life.
In line with Chiesi Group’s sustainable development strategy, Chiesi China is also committed to ‘business as a force for good’, striving to create a positive impact on the local environment and communities while operating business in China.